Format
Sort by

Send to

Choose Destination

Links from Protein

Items: 1 to 20 of 79

1.

Functional role of the flexible N-terminal extension of FKBP38 in catalysis.

Kang C, Ye H, Chia J, Choi BH, Dhe-Paganon S, Simon B, Schütz U, Sattler M, Yoon HS.

Sci Rep. 2013 Oct 22;3:2985. doi: 10.1038/srep02985.

2.

Phosphatidic acid activates mammalian target of rapamycin complex 1 (mTORC1) kinase by displacing FK506 binding protein 38 (FKBP38) and exerting an allosteric effect.

Yoon MS, Sun Y, Arauz E, Jiang Y, Chen J.

J Biol Chem. 2011 Aug 26;286(34):29568-74. doi: 10.1074/jbc.M111.262816. Epub 2011 Jul 7.

3.

New structural aspects of FKBP38 activation.

Maestre-Martínez M, Haupt K, Edlich F, Jahreis G, Jarczowski F, Erdmann F, Fischer G, Lücke C.

Biol Chem. 2010 Oct;391(10):1157-67. doi: 10.1515/BC.2010.122.

PMID:
20707607
4.

Characterization of a Bcl-XL-interacting protein FKBP8 and its splice variant in human RPE cells.

Chen Y, Sternberg P, Cai J.

Invest Ophthalmol Vis Sci. 2008 Apr;49(4):1721-7. doi: 10.1167/iovs.07-1121.

5.

Solution structure of the FK506-binding domain of human FKBP38.

Maestre-Martínez M, Edlich F, Jarczowski F, Weiwad M, Fischer G, Lücke C.

J Biomol NMR. 2006 Mar;34(3):197-202. No abstract available.

PMID:
16604427
6.

Molecular characterization of FK-506 binding protein 38 and its potential regulatory role on the anti-apoptotic protein Bcl-2.

Kang CB, Feng L, Chia J, Yoon HS.

Biochem Biophys Res Commun. 2005 Nov 11;337(1):30-8.

PMID:
16176796
7.

Interaction of presenilins with FKBP38 promotes apoptosis by reducing mitochondrial Bcl-2.

Wang HQ, Nakaya Y, Du Z, Yamane T, Shirane M, Kudo T, Takeda M, Takebayashi K, Noda Y, Nakayama KI, Nishimura M.

Hum Mol Genet. 2005 Jul 1;14(13):1889-902. Epub 2005 May 19.

9.

Involvement of FKBP6 in hepatitis C virus replication.

Kasai H, Kawakami K, Yokoe H, Yoshimura K, Matsuda M, Yasumoto J, Maekawa S, Yamashita A, Tanaka T, Ikeda M, Kato N, Okamoto T, Matsuura Y, Sakamoto N, Enomoto N, Takeda S, Fujii H, Tsubuki M, Kusunoki M, Moriishi K.

Sci Rep. 2015 Nov 16;5:16699. doi: 10.1038/srep16699.

10.

Ca2+/S100 proteins inhibit the interaction of FKBP38 with Bcl-2 and Hsp90.

Shimamoto S, Tsuchiya M, Yamaguchi F, Kubota Y, Tokumitsu H, Kobayashi R.

Biochem J. 2014 Feb 15;458(1):141-52. doi: 10.1042/BJ20130924.

PMID:
24295050
11.

The FKBP38 catalytic domain binds to Bcl-2 via a charge-sensitive loop.

Haupt K, Jahreis G, Linnert M, Maestre-Martínez M, Malesevic M, Pechstein A, Edlich F, Lücke C.

J Biol Chem. 2012 Jun 1;287(23):19665-73. doi: 10.1074/jbc.M111.317214. Epub 2012 Apr 20.

12.

FK506 binding protein 8 peptidylprolyl isomerase activity manages a late stage of cystic fibrosis transmembrane conductance regulator (CFTR) folding and stability.

Hutt DM, Roth DM, Chalfant MA, Youker RT, Matteson J, Brodsky JL, Balch WE.

J Biol Chem. 2012 Jun 22;287(26):21914-25. doi: 10.1074/jbc.M112.339788. Epub 2012 Apr 2.

13.

FKBP38 peptidylprolyl isomerase promotes the folding of cystic fibrosis transmembrane conductance regulator in the endoplasmic reticulum.

Banasavadi-Siddegowda YK, Mai J, Fan Y, Bhattacharya S, Giovannucci DR, Sanchez ER, Fischer G, Wang X.

J Biol Chem. 2011 Dec 16;286(50):43071-80. doi: 10.1074/jbc.M111.269993. Epub 2011 Oct 26.

14.

The essential role of FKBP38 in regulating phosphatase of regenerating liver 3 (PRL-3) protein stability.

Choi MS, Min SH, Jung H, Lee JD, Lee TH, Lee HK, Yoo OJ.

Biochem Biophys Res Commun. 2011 Mar 11;406(2):305-9. doi: 10.1016/j.bbrc.2011.02.037. Epub 2011 Feb 12.

PMID:
21320469
15.

A charge-sensitive loop in the FKBP38 catalytic domain modulates Bcl-2 binding.

Maestre-Martínez M, Haupt K, Edlich F, Neumann P, Parthier C, Stubbs MT, Fischer G, Lücke C.

J Mol Recognit. 2011 Jan-Feb;24(1):23-34. doi: 10.1002/jmr.1020.

PMID:
20140889
16.

FKBP38 protects Bcl-2 from caspase-dependent degradation.

Choi BH, Feng L, Yoon HS.

J Biol Chem. 2010 Mar 26;285(13):9770-9. doi: 10.1074/jbc.M109.032466. Epub 2010 Feb 5.

17.

Re-evaluating the roles of proposed modulators of mammalian target of rapamycin complex 1 (mTORC1) signaling.

Wang X, Fonseca BD, Tang H, Liu R, Elia A, Clemens MJ, Bommer UA, Proud CG.

J Biol Chem. 2008 Nov 7;283(45):30482-92. doi: 10.1074/jbc.M803348200. Epub 2008 Aug 1.

18.

A single-amino-acid mutation in hepatitis C virus NS5A disrupting FKBP8 interaction impairs viral replication.

Okamoto T, Omori H, Kaname Y, Abe T, Nishimura Y, Suzuki T, Miyamura T, Yoshimori T, Moriishi K, Matsuura Y.

J Virol. 2008 Apr;82(7):3480-9. doi: 10.1128/JVI.02253-07. Epub 2008 Jan 23.

19.

Bcl-2 localized at the nuclear compartment induces apoptosis after transient overexpression.

Portier BP, Taglialatela G.

J Biol Chem. 2006 Dec 29;281(52):40493-502. Epub 2006 Nov 7.

20.

Hepatitis C virus non-structural protein NS5A interacts with FKBP38 and inhibits apoptosis in Huh7 hepatoma cells.

Wang J, Tong W, Zhang X, Chen L, Yi Z, Pan T, Hu Y, Xiang L, Yuan Z.

FEBS Lett. 2006 Aug 7;580(18):4392-400. Epub 2006 Jul 17.

Items per page

Supplemental Content

Write to the Help Desk